Table 2.
Group 1 | Group 2 | Group 3 | Overall P value* | P value† | P value‡ | P value** | |
---|---|---|---|---|---|---|---|
N. of participants | 154 | 59 | 63 | ||||
Drusen type | |||||||
Small hard drusen | 33.8 % | 27.1 % | 19.0 % | 0.091 | |||
RPD | 0.6 % | 22.0 % | 1.6 % | <0.001 | 0.497 | <0.001 | <0.001 |
Soft drusen | 4.5 % | 25.4 % | 8.0 % | <0.001 | 0.110 | <0.001 | <0.001 |
Presence of DLD | 24.7 % | 3.4 % | 9.5 % | <0.001 | 0.015 | 0.275 | <0.001 |
Size of DLD | <0.001 | 0.001 | 1.000 | 0.002 | |||
<125 μm | 80.5 % | 96.6 % | 96.8 % | ||||
> 125 μm | 19.5 % | 3.4 % | 3.2 % | ||||
Pigmentary changes | 39.6 % | 35.6 % | 14.3 % | 0.001 | <0.001 | 0.011 | 0.639 |
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical exudative age-related macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
Drusen-like deposits (DLD) were defined as sub-retinal or sub-retinal pigment epithelial grayish yellow deposits larger than 63 μm in size with irregular but discrete margins
RPD: reticular pseudodrusen
* comparison of all Groups; P value less than 0.05 is considered significant
† comparison of Groups 1 and 3; P value less than 0.016 is considered significant
‡ comparison of Groups 2 and 3; P value less than 0.016 is considered significant
** comparison of Groups 1 and 2; P value less than 0.016 is considered significant